$105M proton therapy center slated for Dallas

cancer - 139.23 Kb
Texas Oncology and Baylor Health Enterprises have selected Irving-Las Colinas as the home for a $105 million proton therapy facility in the Dallas-Fort Worth Metroplex.

Representatives expect construction to begin on the 50,000-square-foot proton therapy facility in 2013, and they anticipate the first patients will be treated in late 2015. Final economic incentives are pending approvals later this month by Irving City Council and Dallas County Utility and Reclamation District.

The facility will provide services through Texas Oncology and will give options in cancer treatment, including the opportunity to participate in clinical trials through US Oncology Research.

The facility will include a proton cyclotron, two isocentric-gantry treatment rooms, a fixed-beam treatment room and image guidance technology. Once completed, it is estimated the proton therapy center will employ about 50 healthcare professionals.

For more about proton therapy, read "Proton therapy profits pivot on prostate cancer," and "KLAS: Providers hesitant to jump on proton therapy bandwagon."

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.